文档介绍：[2] PanJJ,ZhangSW,ChenCB,- rus-binedwithradiotherapyonlong-termprognosisofad- vancednasopharyngealcarcinoma[J].JClinOncol,2009,27(5): 799-804. [3] SheenTS,KoJY, ancer[J].AnnOtolRhinolLaryngol, 1998,107(7):593-597. [4] 朱小东,刘颖新,王安宇,、bcl-A在不同放射敏感性的鼻咽癌组织中的表达及其相关性研究[J].肿瘤防治研究杂志,2004,31(12):768-775. [5] LinHS,BerryGJ,SunZ, recurrentnasopharyngealcarcinoma[J].WorldJSurgOncol, 2006,5(4):62. [6] LeeAW,LiJH,ShiW,:apotentiallyeffi- caciousmodalityfornasopharyngealcarcinoma[J].MolCancer Ther,2003,2(10):961. [7] 刘世喜,杨焕,袁逸铭,[J].中华耳鼻咽喉科杂志,2004, 39(5):278-282. [8] 陈燕,王捷,张钦明,(LMP1)后对放射敏感性的影响[J].广东医学院学报,2002,20(3):167-169. [9] QiuQ,SunW,ChenS,- binationofpAdKDR-tk/GCVsui- herapysystemand 60Coradiotherapy[J].JClinOtorhi- nolaryngolHeadNeckSurg,2010,24(9):414-416. [10] CohenSJ,DobelbowerRJr,LipsitzS,Ⅲ studyofradiotherapyaloneorwith5-fluorouracilandmitomycin-C inpatientswithlocallyadvancedadenocarcinomaofthepancreas: EasternCooperativeOncologyGroupStudyE8282[J].IntJRadiat OncolBiolPhys,2005,62(5):1345-1350. [11] XiaK,LiangD,TangA, CDglyTKplaysaroleinradio-herapyofnasopharyngealcar- cinoma[J].her,2004,11(12):790-796. [12] VordermarkD,KatzerA,BaierK,-spe